 |
Apellis Pharmaceuticals
APLS
|
115 |
$ 19.87 |
-1.44 % |
$ 2.51 B |
USA |
 |
Aptorum Group Limited
APM
|
20.6 |
$ 0.82 |
3.61 % |
$ 4.47 M |
China |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
AbCellera Biologics
ABCL
|
173 |
$ 3.66 |
-1.43 % |
$ 1.09 B |
Canada |
 |
Athersys
ATHX
|
22.6 |
- |
3.77 % |
$ 22.4 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
AVEO Pharmaceuticals
AVEO
|
47.5 |
- |
- |
$ 521 M |
USA |
 |
Axsome Therapeutics
AXSM
|
105 |
$ 163.94 |
-0.07 % |
$ 8.16 B |
USA |
 |
BioDelivery Sciences International
BDSI
|
115 |
- |
-4.8 % |
$ 255 M |
USA |
 |
BridgeBio Pharma
BBIO
|
52.4 |
$ 65.12 |
0.91 % |
$ 12.5 B |
USA |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
CymaBay Therapeutics
CBAY
|
182 |
- |
- |
$ 3.45 B |
USA |
 |
Avid Bioservices
CDMO
|
45.6 |
- |
- |
$ 789 M |
USA |
 |
BioMarin Pharmaceutical
BMRN
|
88.9 |
$ 59.06 |
0.91 % |
$ 11.3 B |
USA |
 |
Checkpoint Therapeutics
CKPT
|
6.83 |
- |
- |
$ 169 M |
USA |
 |
Caladrius Biosciences
CLBS
|
164 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Alpine Immune Sciences
ALPN
|
154 |
- |
- |
$ 2.17 B |
USA |
 |
Clovis Oncology
CLVS
|
65.5 |
- |
-7.23 % |
$ 13 M |
USA |
 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Acasti Pharma
ACST
|
1.97 |
- |
4.01 % |
$ 150 M |
Canada |
 |
CTI BioPharma Corp.
CTIC
|
52.1 |
- |
- |
$ 1.2 B |
USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
81.5 K |
- |
-5.98 % |
$ 34.1 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
3.66 K |
- |
-4.36 % |
$ 27 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
60.8 |
- |
- |
$ 2.18 B |
USA |
 |
Capricor Therapeutics
CAPR
|
31.9 |
$ 25.35 |
-1.92 % |
$ 679 M |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Codexis
CDXS
|
32.9 |
$ 0.97 |
-1.14 % |
$ 71.2 M |
USA |
 |
AgeX Therapeutics
AGE
|
78.4 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Certara
CERT
|
89.6 |
$ 7.44 |
2.69 % |
$ 1.19 B |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Coherus BioSciences
CHRS
|
263 |
$ 1.71 |
3.33 % |
$ 161 M |
USA |
 |
Evofem Biosciences
EVFM
|
68.8 |
- |
7.55 % |
$ 38.1 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |